Live feed16:05:37·1703dINSIDERFilingvia QuantisnowSEC Form 4: Ronsheim Matthew was granted 25,000 shares and sold $11,991 worth of shares (3,759 units at $3.19), increasing direct ownership by 85% to 46,241 unitsByQuantisnow·Wall Street's wire, on your screen.ETTX· Entasis Therapeutics Holdings Inc.Health CareOriginal source